高视医疗(02407.HK) 公布,近日公司全资附属高视泰靓之“人工晶状体植入系统”已获得由广东省药品监督管理局批准的医疗器械注册证。
高视泰靓本次获批的人工晶状体植入系统,主要适用于微小切口白内障手术中的人工晶状体植入手术。(ha/da)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.